Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
City Hospital
Birmingham, Reino UnidoPublications in collaboration with researchers from City Hospital (31)
2013
-
Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST
Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 185-192
-
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
Age and Ageing, Vol. 42, Núm. 1, pp. 70-75
2011
2010
-
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease
International Journal of Cardiology, Vol. 139, Núm. 1, pp. 95-97
-
The prognostic value of biomarkers after a premature myocardial infarction
International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254
2009
-
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: New data in an area of limited evidence
Europace
-
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: Implications for clinical management and prognosis
European Heart Journal, Vol. 30, Núm. 2, pp. 139-151
-
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation
European Heart Journal, Vol. 30, Núm. 8, pp. 932-939
-
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting
Chest, Vol. 135, Núm. 4, pp. 983-990
-
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation
International Journal of Cardiology, Vol. 132, Núm. 2, pp. 227-232
2008
-
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting
QJM
-
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk
Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559
-
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting
Chest, Vol. 134, Núm. 3, pp. 559-567
-
Is thrombogenesis related to residual platelet function in ischaemic heart disease?
European Heart Journal
-
Mortality in patients with atrial fibrillation: Improving or not?
Europace
-
The impact of statin use on atrial fibrillation
QJM, Vol. 101, Núm. 11, pp. 845-861
2007
-
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes
Cerebrovascular Diseases, Vol. 24, Núm. 4, pp. 338-342
-
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: Relation to functional data and prognosis
Journal of Internal Medicine, Vol. 262, Núm. 3, pp. 385-392
-
Plasma angiogenin levels in acute coronary syndromes: Implications for prognosis
European Heart Journal, Vol. 28, Núm. 24, pp. 3006-3011
2006
-
Growth hormone therapy and the heart
American Journal of Cardiology, Vol. 97, Núm. 7, pp. 1097-1102